Literature DB >> 17006295

Serotypes, genotypes, and antibiotic susceptibility profiles of group B streptococci causing neonatal sepsis and meningitis before and after introduction of antibiotic prophylaxis.

Monique A J M Trijbels-Smeulders1, Jan L L Kimpen, Louis A A Kollée, Judith Bakkers, Willem Melchers, Lodewijk Spanjaard, Wim J B Wannet, Mieke A A Hoogkamp-Korstanje.   

Abstract

We studied the characteristics of strains isolated from neonates with group B streptococci sepsis and meningitis, before and after the introduction of antibiotic prophylaxis in The Netherlands. In 1999, 1 year after this introduction the serotype and genotype distribution and the susceptibility patterns of the GBS strains had not changed. Penicillins remain drugs of first choice to prevent and treat neonatal GBS disease.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17006295     DOI： 10.1097/01.inf.0000237821.65559.08

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  8 in total

1.  Pharmacokinetics of penicillin g in very-low-birth-weight neonates.

Authors:  Tuuli Metsvaht; Kersti Oselin; Mari-Liis Ilmoja; Kaili Anier; Irja Lutsar
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

2.  Insulin modulates the inflammatory granulocyte response to streptococci via phosphatidylinositol 3-kinase.

Authors:  Sybille Kenzel; Miriam Mergen; Julius von Süßkind-Schwendi; Julia Wennekamp; Sachin D Deshmukh; Monika Haeffner; Antigoni Triantafyllopoulou; Sebastian Fuchs; Susan Farmand; Sandra Santos-Sierra; Jochen Seufert; Timo K van den Berg; Taco W Kuijpers; Philipp Henneke
Journal:  J Immunol       Date:  2012-09-26       Impact factor: 5.422

3.  Pathogen- and Type-Specific Changes in Invasive Bacterial Disease Epidemiology during the First Year of the COVID-19 Pandemic in The Netherlands.

Authors:  Anneke Steens; Mirjam J Knol; Wieke Freudenburg-de Graaf; Hester E de Melker; Arie van der Ende; Nina M van Sorge
Journal:  Microorganisms       Date:  2022-05-05

4.  Neurological complications after neonatal bacteremia: the clinical characteristics, risk factors, and outcomes.

Authors:  Shih-Ming Chu; Jen-Fu Hsu; Chiang-Wen Lee; Reyin Lien; Hsuan-Rong Huang; Ming-Chou Chiang; Ren-Huei Fu; Ming-Horng Tsai
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

Review 5.  Interaction of Streptococcus agalactiae and Cellular Innate Immunity in Colonization and Disease.

Authors:  Sybille Landwehr-Kenzel; Philipp Henneke
Journal:  Front Immunol       Date:  2014-10-29       Impact factor: 7.561

Review 6.  Systematic review of Group B Streptococcal capsular types, sequence types and surface proteins as potential vaccine candidates.

Authors:  Fiorella Bianchi-Jassir; Proma Paul; Ka-Ning To; Clara Carreras-Abad; Anna C Seale; Elita Jauneikaite; Shabir A Madhi; Neal J Russell; Jenny Hall; Lola Madrid; Quique Bassat; Gaurav Kwatra; Kirsty Le Doare; Joy E Lawn
Journal:  Vaccine       Date:  2020-09-02       Impact factor: 3.641

7.  Neurodevelopment Outcome of Neonates Treated With Intraventricular Colistin for Ventriculitis Caused by Multiple Drug-Resistant Pathogens-A Case Series.

Authors:  Kashif Hussain; Muhammad Sohail Salat; Gul Ambreen; Javaid Iqbal
Journal:  Front Pediatr       Date:  2021-01-20       Impact factor: 3.418

Review 8.  Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses.

Authors:  Lola Madrid; Anna C Seale; Maya Kohli-Lynch; Karen M Edmond; Joy E Lawn; Paul T Heath; Shabir A Madhi; Carol J Baker; Linda Bartlett; Clare Cutland; Michael G Gravett; Margaret Ip; Kirsty Le Doare; Craig E Rubens; Samir K Saha; Ajoke Sobanjo-Ter Meulen; Johan Vekemans; Stephanie Schrag
Journal:  Clin Infect Dis       Date:  2017-11-06       Impact factor: 20.999
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.